Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Ratings ...
Shares of West Pharmaceutical Services Inc. WST slid 2.63% to $225.80 Tuesday, on what proved to be an all-around favorable ...
StockStory.org on MSN22h
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback